Triple combination of hepatic arterial infusion chemotherapy, immune checkpoint inhibitors, and tyrosine kinase inhibitors for treatment of advanced hepatocellular carcinoma: more robust evidence is still needed
@article{CCO129757,
author = {Mohammad Saeid Rezaee-Zavareh and Ju Dong Yang},
title = {Triple combination of hepatic arterial infusion chemotherapy, immune checkpoint inhibitors, and tyrosine kinase inhibitors for treatment of advanced hepatocellular carcinoma: more robust evidence is still needed},
journal = {Chinese Clinical Oncology},
volume = {13},
number = {5},
year = {2024},
keywords = {},
abstract = {},
issn = {2304-3873}, url = {https://cco.amegroups.org/article/view/129757}
}